# Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/once-daily-upadacitinib-versus-placebo-in-adolescents-and-adults-with-moderate/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Emma Guttman‐Yassky,Henrique D. Teixeira,Eric L. Simpson,Kim Papp,Aileen L. Pangan,Andrew Blauvelt,Diamant Thaçi,Chia‐Yu Chu,Hyuck-Ki Hong,Norito Katoh,Amy S. Paller,Brian Calimlim,Yihua Gu,Xiaofei Hu,Meng Liu,Yang Yang,John Liu,Allan R. Tenorio,Alvina D. Chu,Alan D. Irvine |
| Citations | 564 |
| DOI | 10.1016/s0140-6736(21)00588-2 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3164705475 |
| PMID | 34023008 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Chia‐Yu Chu](https://scholariq.org/researchers/chia-yu-chu/)
- [Alan D. Irvine](https://scholariq.org/researchers/alan-d-irvine/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.